Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

Krishna Ella, chairman & MD,  Bharat Biotech
Premium

Krishna Ella, chairman & MD, Bharat Biotech

Sohini Das Mumbai
Covaxin maker Bharat Biotech is yet to come out with a formal pricing for its Covid-19 vaccine, but company chief Krishna Ella said it would ideally like to have the “maximum possible price”.
 
Covaxin is being sold for $15-20 in the international markets. The company is in process of ramping up its vaccine production capacity to 700 million doses annually and is also pursuing approval for it in 60 countries. In Mexico, the Philippines, and Iran, it is already fetching $15-20 per shot.
 
Ella, CMD of the Hyderabad-based company, told a television channel: “As a company we would

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 22 2021 | 11:10 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com